Fidelity International
SGMO

Fidelity International’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Fidelity International’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-211,121
Closed -$2.34M – 533
2015
Q2 		$2.34M Sell
211,121
-55,297
-21% -$713K 0.01% 460
2015
Q1 		$4.18M Buy
+266,418
New +$4.12M 0.01% 423
2014
Q3 		– Sell
-352,335
Closed -$5.38M – 496
2014
Q2 		$5.38M Buy
352,335
+46,730
+15% +$672K 0.02% 397
2014
Q1 		$5.53M Buy
+305,605
New +$5.89M 0.02% 407

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity International's SGMO Position: Q3 2015 in Review

Fidelity International sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2015, closing a stake of 211,121 shares — an estimated $2.34M sold.

Fidelity International first reported a position in SGMO in Q1 2014 and held it in 4 quarters. The position peaked at $5.53M in Q1 2014. 141 funds tracked by Wall St. Rank hold SGMO as of Q3 2015.

  • Fidelity International reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2015 after selling out during the quarter.
  • Fidelity International sold 211,121 SANGAMO THERAPEUTICS INC shares in Q3 2015, an estimated $2.34M.
  • Fidelity International first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 4 quarters.
  • Fidelity International's SANGAMO THERAPEUTICS INC position peaked at $5.53M in Q1 2014.
  • 141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2015.

Based on Fidelity International's 13F filing for Q3 2015, filed 10 Nov 2015.